BRAF and non-small cell lung carcinoma: Mutations in EGFR, KRAS and driver mutations in ALK, BRAF, PIK3CA, AKT1, MAP2K1, and MET in NSCLC [70] are also examples of predictive biomarkers as well as BRAF mutation in melanoma [71].